Depends on context

Cocamidopropyl PG-Dimonium Chloride Phosphate

Last reviewed

What it is

Cocamidopropyl PG-Dimonium Chloride Phosphate is a coconut-oil-derived, phospholipid-type conditioning agent and mild surfactant — a quaternary ammonium compound built on a phosphate-ester backbone, structurally gentler than the simple-quat disinfectant actives like benzalkonium chloride. Formulators use it for antistatic effect, hair and skin conditioning, and mild foam-stabilizing/cleansing action; it appears across shampoos, conditioners, leave-in treatments, facial cleansers, lotions, and some baby-wipe formulations, sold under trade names including Croda's Arlasilk PTC (also marketed historically as Arlasilk Phospholipid PTC) and Colonial Chemical's Cola Lipid C. It is listed in the European Commission's CosIng cosmetic-ingredient database (Ref. No. 32936) for antistatic and hair-conditioning functions specifically (skin conditioning is a use claimed by suppliers, but is not one of the two functions CosIng itself lists for the ingredient).

Why it's flagged

No independent U.S. Cosmetic Ingredient Review (CIR) safety monograph specific to this exact compound turned up in a search of CIR's published reports — unlike many common cosmetic ingredients, it hasn't received that kind of dedicated expert-panel toxicological review, which is part of why infant-specific data stays thin. It isn't wholly unreviewed, though: it's an approved, listed ingredient in the EU's CosIng registry, and EWG's Skin Deep database rates it low on three specific toxicity categories — cancer, allergy/immunotoxicity, and developmental/reproductive toxicity. But EWG's own overall hazard score for it is a range, '1-4 depending on usage' (higher for inhalable product forms like sprays), not a flat 'low,' and the profile separately flags 'Use restrictions (high)' and lists the ingredient as restricted under EWG's own Verified program — allowed only when a company supplies adequate safety substantiation — all against a 'Limited' evidence base, so this is closer to 'reviewed and provisionally reassuring' than 'cleared.' The most concrete adverse-effect evidence is two independent published case reports of allergic contact dermatitis, a decade apart: Lorenzi, Placucci, Vincenzi & Tosti (1996, Contact Dermatitis, 34(2):149–150) and Roberts, Williams & Tate (2006, Contact Dermatitis, 55(6):369–370, in a facial hydrating lotion that also contained panthenol). The 2006 authors describe contact allergy to this ingredient as 'rare' — two published cases against decades of commercial use is still a thin signal, not a pattern, but it's two independently reported cases, not the single case the original draft of this entry cited.

How concerned to be

Context-dependent remains the fair call, and for a slightly fuller reason than the draft gave: there's a confirmed-but-rare capacity to cause allergic contact dermatitis — documented in two independent published case reports a decade apart, not one — no dedicated infant- or CIR-level safety review, and a genuinely mixed (not uniformly reassuring) picture in the sources that do exist. EWG's Skin Deep rates the ingredient low on cancer, allergy/immunotoxicity, and developmental/reproductive toxicity specifically, but it also flags 'Use restrictions (high)' and lists the ingredient as restricted under its own EWG VERIFIED program (allowed only with company-supplied substantiation), all on a 'Limited' evidence base. For a baby with typical skin, that combination still reads as low-stakes reassurance rather than caution — this ingredient isn't behaving like the harsher industrial quats used in disinfectants. For a baby with eczema, a known contact allergy, or a family history of sensitive-skin reactions, the case-report history is a legitimate reason to lean toward a wipe formulated without any conditioning quat — not because this one ingredient is uniquely dangerous, but because it's thinly studied and a documented (if rare) sensitizer shows up twice, independently, in the literature. Evidence gap and documented hazard are still different things here — this entry has a real amount of each, not a pile of either.

What it's called on a label

Look for any of these on an ingredient list: Arlasilk Phospholipid PTC, Cola Lipid C, Cocamidopropyl Propylene Glycol-Dimonium Chloride Phosphate, Cocamidopropyl PG-Dimonium Chloride Phosphate.

Sources

  1. Cocamidopropyl PG-Dimonium Chloride Phosphate — Skin Deep Ingredient Profile, Environmental Working Group (EWG), Skin Deep Cosmetics Database (2026)
  2. Contact sensitization to cocamidopropyl PG-dimonium chloride phosphate in a cosmetic cream, Contact Dermatitis (Lorenzi S, Placucci F, Vincenzi C, Tosti A.) (1996)
  3. Allergic contact dermatitis to panthenol and cocamidopropyl PG dimonium chloride phosphate in a facial hydrating lotion, Contact Dermatitis (Roberts H, Williams J, Tate B.) (2006)
  4. Cocamidopropyl PG-Dimonium Chloride Phosphate (CosIng Ref. No. 32936), European Commission, CosIng — Cosmetic Ingredient Database (2026)